Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 4Lymphoid 3Other hematologic neoplasm 2Myeloid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 985Leukemia 733Leukemia, Lymphocytic, Chronic, B-Cell 665Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Myelodysplastic Syndromes 502Lymphoma 340Leukemia, Myelogenous, Chronic, BCR-ABL Positive 308Lymphoma, Non-Hodgkin 294Hematologic Neoplasms 257Lymphoma, Follicular 223Multiple Myeloma 213Burkitt Lymphoma 209Hodgkin Disease 198Lymphoma, Large B-Cell, Diffuse 194Lymphoma, Mantle-Cell 193Lymphoma, B-Cell, Marginal Zone 189Leukemia, Myelomonocytic, Chronic 181Leukemia, Myeloid, Chronic-Phase 171Recurrence 167Myeloproliferative Disorders 165Congenital Abnormalities 140Lymphoma, Large-Cell, Immunoblastic 132Leukemia, Myeloid, Accelerated Phase 118Blast Crisis 115Anemia, Refractory, with Excess of Blasts 114Waldenstrom Macroglobulinemia 103Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 102Primary Myelofibrosis 94Graft vs Host Disease 88Neoplasms, Plasma Cell 84

Interventions

Melphalan 2Cyclophosphamide 2Busulfan 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Rituximab 1Levetiracetam 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × beta-Thalassemia × Other hematologic neoplasm × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡